Evaluation of risk for atherosclerosis in Alagille syndrome and progressive familial intrahepatic cholestasis: Two congenital cholestatic diseases with different lipoprotein metabolisms
Evaluation of risk for atherosclerosis in Alagille syndrome and progressive familial intrahepatic cholestasis: Two congenital cholestatic diseases with different lipoprotein metabolisms
复制标题
DOI:
10.1016/j.jpeds.2004.10.047
复制
发表时间:
2005-03-01
影响因子:
5.1
通讯作者:
Kobayashi, K
中科院分区:
文献类型:
--
作者:
Nagasaka, H;Yorifuji, T;Kobayashi, K
Objectives To evaluate the risk for atherosclerosis in Alagille syndrome (AGS) and progressive familial intrahepatic cholestasis (PFIC) oil the basis of lipoprotein metabolism and by ultrasonography.Study design Five patients with AGS and 5 with PFIC, ages 3 to 4 years, were enrolled. Intimal-medial thickness and wall stiffness of the common carotid artery were examined by ultrasonography. Serum levels of lipids and lipoproteins were determined. Further, the chemical composition of LDL and its ability to transform macrophages into foam cells were determined.Results Intimal-medial thickness and wall stiffness were increased in patients with PFIC but not ill patients with AGS. Total cholesterol, LDL cholesterol, HDL cholesterol, and lipoprotein X were remarkably increased in patients with AGS, whereas in patients with PFIC, an increase in triglyceride and a decrease in HDL cholesterol were the prominent findings. However, despite the normal LDL cholesterol level, oxidized LDL level was strikingly high in patients with PFIC. LDLs from patients with PFIC had high TG contents and exhibited high abilities to transform macrophages into foam cells.Conclusions These findings suggest that patients with PFIC are at high risk for cardiovascular disorders involving atherosclerosis.